Recent advances in glucagon receptor (GCGR) agonists show promise for enhancing catabolic metabolism, but concerns persist. Potential side effects include increased heart rates, hepatic glucose ...

STATE COLLEGE, PA, UNITED STATES, January 28, 2025 /EINPresswire.com/ -- INDIGO Biosciences, a premier provider of cell-based assay solutions, has introduced its new ...

Sun Pharmaceutical Industries Ltd. has divulged incretin analogues acting as dual agonists of gastric inhibitory polypeptide (GIPR) receptor/GLP-1 or GLP-1/glucagon receptor (GCGR) or triple agonists ...

In addition to impaired insulin secretion, type 2 diabetic patients also have elevated levels of glucagon, which worsens hyperglycemia by increasing glucose production by the liver. Type 2 ...

glucagon receptor (GCGR), and glucose-dependent insulinotropic polypeptide (GIP) receptor. It is believed that through these interactions, Retatrutide might influence glucose and lipid metabolism ...

Glucagon prescriptions for severe hypoglycemia in Medicaid initially decreased from 2012 to 2018 but increased between 2019 and 2023 following the introduction of newer products. Glucagon ...

and glucagon receptor (GCGR) dual agonist. OXM is a naturally-occurring gut hormone that activates GLP1R and GCGR, thereby decreasing food intake while increasing energy expenditure, thus ...

has introduced its new Glucagon Receptor (GCGR) Reporter Assay to accompany its already popular Glucagon-like Peptide-1 Receptor (GLP-1R) and Gastric Inhibitory Polypeptide Receptor (GIPR ...